5-Methylmethiopropamine Explained
5-Methylmethiopropamine (5-MMPA, mephedrene) is a stimulant drug which is a ring-substituted derivative of methiopropamine. It is not a substituted cathinone derivative like mephedrone, as it lacks a ketone group at the β position of the aliphatic side chain, but instead more closely resembles substituted amphetamines. It has been sold as a designer drug, first being identified in Germany in June 2020.[1] [2] [3]
See also
Notes and References
- [<!--(not yet on website) EU-EWS-SITREP-2020-0002.pdf --> EU Early Warning System Situation Report. Situation report 2 ]. 10 August 2020 . European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) .
- Web site: Info . www.aekwien.at . 2021-05-13.
- https://www.emcdda.europa.eu/system/files/publications/13464/20205648_TD0320796ENN_PDF_rev.pdf New psychoactive substances: global markets, glocal threats and the COVID-19 pandemic. European Monitoring Center for Drugs and Drug Addiction, December 2020